Mithra Continues to Confirm its Contraception Market Leader Position in Belgium

  • Mithra realized its best selling month in June 2016
  • Mithra remains leader in contraception on the Belgian market (in terms of cycles)
  • Mithra becomes N°2 in terms of value ahead of Organon (MSD)
  • The trend in the market confirms Mithra’s Estetrol-based developments

Liège, Belgium 26 July 2016 – In terms of cycles, Mithra announces that it recorded a 2.8%[3] market share growth compared to June 2015. This represents a significant growth given the 1%[4] decrease recorded on the Belgian contraception market over the same period.

Read the press release